Camille L. Gérard
-
- Cancer Immunotherapy and Biomarkers 19
- CAR-T cell therapy research 8
- Colorectal Cancer Treatments and Studies 2
-
- Immunotherapy and Immune Responses 11
-
- Brain Metastases and Treatment 3
-
- Ocular Oncology and Treatments 4
-
- Melanoma and MAPK Pathways 8
-
- Computational Drug Discovery Methods 2
- Co-authors
- Olivier MichielinMichel A. CuendetAlexandre WickyKrisztián HomicskóBerna C. ÖzdemirJulie DelyonLisa ZimmerFlorentia Dimitriou
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Camille L. Gérard
32 papers receiving 298 citations
Peers
Comparison fields: 5 of 74
- Oncology 196
- Immunology 80
- Pulmonary and Respiratory Medicine 85
- Genetics 27
- Ophthalmology 16
Countries citing papers authored by Camille L. Gérard
This map shows the geographic impact of Camille L. Gérard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille L. Gérard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille L. Gérard more than expected).
Fields of papers citing papers by Camille L. Gérard
This network shows the impact of papers produced by Camille L. Gérard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille L. Gérard. The network helps show where Camille L. Gérard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Camille L. Gérard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 72 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 17 | |
| 17 | 2019 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 抗糸球体基底膜(GBM)腎炎におけるインターロイキン(IL)10遺伝子導入によるタンパク尿症の減少 | 1996 | 1 |
| 20 | 1993 | 8 |
About Camille L. Gérard
Camille L. Gérard is a scholar working on Chemical Health and Safety, Oncology and Immunology, having authored 33 papers that have together received 300 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (8 papers), Melanoma and MAPK Pathways (8 papers), Ocular Oncology and Treatments (4 papers), Brain Metastases and Treatment (3 papers), Computational Drug Discovery Methods (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (196 citations), Immunology (80 citations) and Pulmonary and Respiratory Medicine (85 citations). Camille L. Gérard has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Olivier Michielin, Michel A. Cuendet, Alexandre Wicky, Krisztián Homicskó, Berna C. Özdemir, Julie Delyon, Lisa Zimmer, Florentia Dimitriou, Georgina V. Long and Paolo A. Ascierto.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.